Clinical Trial Update: A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

Completed Phase 2 trial evaluating an optimized standard protocol for severe aplastic anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Aplastic Anemia | Phase 2 | Status: COMPLETED